| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 May 2024 | 28 Mar 2024 |
| SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve the Audited Standalone Financial Results of the company for the quarter and year ended March 31 2024. The Board of Directors may consider a proposal to recommend dividend on the equity shares of the company for the financial year ended March 31 2024. Final Dividend & Audited Results (As per BSE Bulletin dated on 28/03/2024) The Board of Directors approved and adopted Audited Financial Results for the quarter and year ended March 31, 2024. Recommendation of Dividend @ 10% on paid up capital of the company (As Per BSE Announcement dated on 30.05.2024) | ||
| Board Meeting | 14 Feb 2024 | 29 Dec 2023 |
| SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Pursuant to Regulation 29(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that a meeting of the Board of Directors of the Company will be held at 03:00 P.M. on Wednesday the 14th day of February 2024 at the Corporate Office of the Company at 701/702 Business Square M. A. Road Andheri (West) Mumbai - 400 058 inter alia to consider and take on record the Un-Audited Financial Results of the Company under Indian Accounting Standards (Ind-As) for the quarter ended December 31 2023. The Company shall intimate to the exchanges the Un-Audited financial results upon the conclusion of the aforesaid Board Meeting and will arrange for the announcement of the same in the Press and on the companys website as required under the Listing Agreement. We wish to inform you that the Board has considered and took on record the Un-Audited Financial Results of the company for the quarter ended December 31, 2023. (As Per BSE Announcement Dated on: 14/02/2024) | ||
| Board Meeting | 8 Nov 2023 | 26 Sep 2023 |
| SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the un-audited standalone financial results for the quarter and half year ended September 30 2023 The Board at its meeting held today has considered and took on record the Un-audited financial results for the quarter and half year ended September 30, 2023 Approval of Results for the quarter and half year ended September 30, 2023 (As per BSE Announcement Dated on 08/11/2023) Newspaper Publication - Extract of UFR 30/09/2023 (As Per BSE Announcement Dated on 23/11/2023) | ||
| Board Meeting | 14 Aug 2023 | 30 Jun 2023 |
| SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve the Un-Audited Financial Results of the Company under Indian Accounting Standards (Ind-As) for the quarter ended June 30 2023. SAMRAT PHARMACHEM LIMITED has informed BSE about Board Meeting to be held on 14 Aug 2023 to consider financial statements for the period ended June 2023. Financial results. We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday, August 14, 2023, the Board has considered and took on record the attached Un-Audited Standalone Financial Results of the Company for the quarter ended June 30, 2023. The meeting of the Board of Directors of the Company commenced at 02:30 P.M. and concluded at 03:45 P.M. The Board of Directors at its meeting held today has considered and took on record the attached Un-audited Standalone Financial Results for the quarter ended June 30, 2023. (As Per BSE Announcement Dated on 14.08.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
